Indazole Compounds As Irak4 Inhibitors

Patent No. EP3092226 (titled "Indazole Compounds As Irak4 Inhibitors") was filed by Aurigene Discovery on Jan 7, 2015. The application was issued on Mar 13, 2019.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Company	Opposition Date	Representative
BAYER	Dec 11, 2019	KONIG

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

Date
Description

Get instant alerts for new documents

Jan 15, 2021
Communication to the parties concerning the termination of the opposition proceedings (opponent)
Jan 15, 2021
Communication to the parties concerning the termination of the opposition proceedings (proprietor)
Jan 12, 2021
Termination of the opposition proceedings with revocation of patent
Oct 30, 2020
(Electronic) Receipt
Oct 30, 2020
Advice of delivery
Oct 30, 2020
Communication about missing advice of delivery
Oct 30, 2020
Letter accompanying subsequently filed items
Oct 1, 2020
Advice of delivery
Sep 24, 2020
Acknowledgement of a document
Sep 24, 2020
Acknowledgement of a document
Sep 24, 2020
Decision revoking the European patent
Sep 24, 2020
Grounds for the decision (Annex) - opposition
Sep 24, 2020
Internal form - Opposition/addressees
Sep 24, 2020
Means of redress
Sep 16, 2020
Decision of the Opposition Division and instruction
May 29, 2020
Document concerning representation
Jan 9, 2020
Communication of a notice of opposition and request to file observations
Jan 9, 2020
Notice of further oppositions to opponent(s)
Dec 17, 2019
Communication of a notice of opposition - first information to patent proprietor
Dec 11, 2019
(Electronic) Receipt
Dec 11, 2019
Citation in opposition procedure - 001
Dec 11, 2019
Citation in opposition procedure - 001
Dec 11, 2019
Citation in opposition procedure - 001
Dec 11, 2019
Citation in opposition procedure - 001
Dec 11, 2019
Citation in opposition procedure - 001
Dec 11, 2019
Citation in opposition procedure - 002
Dec 11, 2019
Citation in opposition procedure - 002
Dec 11, 2019
Citation in opposition procedure - 003
Dec 11, 2019
Consolidated list of cited opposition documents
Dec 11, 2019
International publication (Pamphlet)
Dec 11, 2019
Notice of opposition
Dec 11, 2019
Notice of opposition
Mar 25, 2019
Transmission of the certificate for a European patent pursuant to Rule 74 EPC
Feb 14, 2019
Decision to grant a European patent
Dec 20, 2018
(Electronic) Receipt
Dec 20, 2018
Filing of the translations of the claims
Dec 20, 2018
French translation of claims
Dec 20, 2018
German translation of the claims
Dec 20, 2018
Letter accompanying subsequently filed items
Sep 12, 2018
Bibliographic data of the European patent application
Sep 12, 2018
Communication about intention to grant a European patent
Sep 12, 2018
Text intended for grant (clean copy)
Sep 12, 2018
Text intended for grant (version for approval)
Aug 20, 2018
Acknowledgement of receipt of third party observations
Aug 20, 2018
Transmittal of third party observations to applicant
Jul 23, 2018
(Electronic) Receipt
Jul 23, 2018
Letter accompanying subsequently filed items
Jul 23, 2018
Observations by third parties
Jun 29, 2018
(Electronic) Receipt
Jun 29, 2018
Amended description with annotations
Jun 29, 2018
Description
Jun 29, 2018
Letter accompanying subsequently filed items
Jun 29, 2018
Reply to communication from the Examining Division
Feb 26, 2018
Annex to the communication
Feb 26, 2018
Communication from the Examining Division
Feb 23, 2018
Acknowledgement of receipt of third party observations
Feb 23, 2018
Transmittal of third party observations to applicant
Feb 13, 2018
(Electronic) Receipt
Feb 13, 2018
Letter accompanying subsequently filed items
Feb 13, 2018
Observations by third parties
Dec 14, 2017
(Electronic) Receipt
Dec 14, 2017
Amended claims with annotations
Dec 14, 2017
Amended description with annotations
Dec 14, 2017
Claims
Dec 14, 2017
Description
Dec 14, 2017
Letter accompanying subsequently filed items
Dec 14, 2017
Reply to communication from the Examining Division
Oct 25, 2017
Acknowledgement of receipt of third party observations
Oct 25, 2017
Transmittal of third party observations to applicant
Oct 19, 2017
(Electronic) Receipt
Oct 19, 2017
Letter accompanying subsequently filed items
Oct 19, 2017
Observations by third parties
Sep 8, 2017
Annex to the communication
Sep 8, 2017
Communication from the Examining Division
Aug 17, 2017
Examination started
Jun 21, 2017
(Electronic) Receipt
Jun 21, 2017
Letter accompanying subsequently filed items
Jun 21, 2017
Statement of non-availability of priority search results
Apr 26, 2017
Invitation to file a copy of search results(priority)
Mar 9, 2017
(Electronic) Receipt
Mar 9, 2017
Amended claims filed after receipt of (European) search report
Mar 9, 2017
Amended claims with annotations
Mar 9, 2017
Amendments received before examination
Mar 9, 2017
Letter accompanying subsequently filed items
Oct 19, 2016
Notification on forthcoming publication of bibliographic data
Oct 3, 2016
(Electronic) Receipt
Oct 3, 2016
Letter accompanying subsequently filed items
Oct 3, 2016
Letter concerning the designation and/or extension and/or validation of states
Sep 7, 2016
Communication concerning correction of deficiencies in written opinion/amendment of application/payment of claims fee
Aug 16, 2016
Communication to designated inventor
Aug 16, 2016
Communication to designated inventor
Aug 16, 2016
Communication to designated inventor
Jul 26, 2016
Copy of the international preliminary report on patentability
Jul 8, 2016
(Electronic) Receipt
Jul 8, 2016
Request for entry into the European phase
May 20, 2016
Information on entry into European phase
Aug 3, 2015
Priority document (electronically transmitted)
Aug 3, 2015
Priority document (electronically transmitted)
Jul 16, 2015
Copy of the international search report
Jul 16, 2015
Published international application - A1
Mar 18, 2015
Written opinion of the ISA, boxes No. I to VIII
Mar 18, 2015
Written opinion of the ISA, cover sheet
Mar 18, 2015
Written opinion of the ISA, supplemental box
Jan 30, 2015
Abstract
Jan 30, 2015
Claims
Jan 30, 2015
Description

EP3092226

AURIGENE DISCOVERY

Application Number: EP15703102A
Filing Date: Jan 7, 2015
Status: Revoked; Jan 15, 2021
Publication Date: Mar 13, 2019
External Links: Slate, Register , Google Patents

IP Verse

Indazole Compounds As Irak4 Inhibitors

Patent Summary

Patent Family

Patent Oppositions

Dossier Documents

EP3092226